Trial Site News
Generic selectors
Exact matches only
Search in title
Search in content
Search in posts
Search in pages
  • Register
  • Log In
  • News
  • Video
  • Podcast
  • More
Trial Site News
  • News For You
  • Op-Eds
  • Video
  • Podcasts
  • Investor Watch
  • Write for us
  • News for You
  • Op-Eds
  • Video
  • Podcasts
  • Covid-19
  • Investor Watch

Search Results for life-sciences

Virtual Trials Grow as Organizations Battle Effects of COVID-19

By Joseph Constance  As the COVID-19 pandemic continues to challenge the healthcare ecosystem, many organizations are turning to virtual, or […]

Virtual Trials Grow as Organizations Battle Effects of COVID-19
7 months ago
Share

Investor Watch Series | S2 E4 | Largest Life Sciences Fund In History. Pharma Nervous?

Welcome To Investor Watch In this series will be going over trials, research and other clinical verticals that receive funding. […]

TrialSite News
7 months ago
Share

Blackstone Raises Largest Life Sciences PEG Fund in History & Already Putting Capital to Work: Should Big Pharma be Nervous?

Blackstone has raised more all purpose investment funds than another other private equity group in the United States.  With the […]

Blackstone Raises Largest Life Sciences PEG Fund in History & Already Putting Capital to Work Should Big Pharma be Nervous
8 months ago
Share

SUNY Binghamton Dept of Biomedical Engineering Researchers on the Move Securing Millions in Grants

Binghamton University is one of four university centers in the State University of New York (SUNY) system. Founded originally as a […]

SUNY Binghamton Dept of Biomedical Engineering Researchers on the Move Securing Millions in GrantsSUNY Binghamton Dept of Biomedical Engineering Researchers on the Move Securing Millions in Grants
9 months ago
Share

Targeting Early-Stage Disruptive Biotech Cambridge’s Atlas Ventures Sees Great Demand for its 12th Fund

Despite economic uncertainty due to the continuing COVID-19 pandemic, private equity groups continue to have no problems raising capital from […]

Targeting Early-Stage Disruptive Biotech Cambridge’s Atlas Ventures Sees Great Demand for its 12th Fund
9 months ago
Share

Did Oxford’s COVID-19 Vaccine Fail? Some Troubling Questions about ChAdOx1

Unfortunately, according to interpretation of recent preclinical study monkey data, Oxford University’s SARS-CoV-2 vaccine called ChAdOx1 failed to prevent the study monkey’s from […]

Did Oxford’ COVID-19 Vaccine Fail Some Troubling Questions about ChAdOx1
10 months ago
Share

Utah Doing its Part as UofU & Intermountain Healthcare Seek at Least 300 Patients for COVID-19 Clinical Trials

The COVID-19 clinical trials have come to Utah and Intermountain Healthcare and University of Utah have launched two studies to […]

Utah Doing its Part as UofU & Intermountain Healthcare Seek at Least 300 Patients for COVID-19 Clinical Trials
11 months ago
Share

Detroit-Area Couple Contribute $40m to Leading Cancer Research Center

A local Detroit area couple, active in philanthropy locally and nationally, announced a $40 million gift to the Karmanos Cancer […]

Detroit-Area Couple Contribute $40m to Leading Cancer Research Center
12 months ago
Share

Is the Australian Government doing Enough to Position Australia Biotech for Investors?

Although considerable biotech research and development occurs in Australia, one of the nation’s elite investors is critical of the government […]

Is the Australian Government doing Enough to Position Australia Biotech for Investors
12 months ago
Share

VA Portland Health Care System Participates in Trial Testing Patient-Specific Predictor of Cancer Therapy Response

VA Portland Health Care System (VAPORHCS) joined a growing roster of institutions participate in the 3D-PREDICT clinical trial seeking to […]

VA Portland Health Care System Participates in Trial Testing Patient-Specific Predictor of Cancer Therapy Response
1 year ago
Share

Posts navigation

Older posts
Newer posts

Latest Podcasts

Alan Cannell talks COVID-19: Nobody Likes Cheap Solutions | Podcast S2 E41

Dr. Pierre Kory Talks Covid-19, Ivermectin and the FLCCC | Podcast E43

An Interview With Patricia Carter: Patient Engagement and Retention in Clinical Trials

Dr. Negin Hajizadeh: Researchers Finding A Very Effective Treatment For Covid-19 In New Study

Dr. Jean-Jacques Rajter and Dr. Juliana Cepelowicz Rajter Discuss Ivermectin In Broward County | Podcast S2 E 27

159 W Broadway, Suite 200
Salt Lake City, UT 84101

[email protected]

Connect With Us

TRIALSITE NEWS IS THE ONLY DIGITAL MEDIA DEDICATED 100% TO TRANSPARENT AND OPEN COVERAGE OF CLINICAL RESEARCH TRIAL SITES AROUND THE GLOBE. BASED IN THE SILICON SLOPES IN DOWNTOWN SALT LAKE CITY, UTAH, WE ARE FOUNDED BY A TEAM OF EXPERTS IN THE CLINICAL TRIALS INDUSTRY AND DEDICATED TO TRANSPARENCY, QUALITY AND CLINICAL TRIAL INNOVATION.

© 2021 TRIALSITE NEWS. ALL RIGHTS RESERVED.